Evidence of pleiotropy by statins: leukocyte Rho kinase (ROCK) activity and pretreated statin before percutaneous coronary interventions are clinical vascular outcome predictors

Int J Cardiol. 2014 Sep;176(1):250-3. doi: 10.1016/j.ijcard.2014.06.059. Epub 2014 Jul 6.
No abstract available

Keywords: Inflammation; Percutaneous coronary intervention; Rho kinase; Statin.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Enzyme Activation / drug effects
  • Enzyme Activation / physiology
  • Female
  • Genetic Pleiotropy / drug effects
  • Genetic Pleiotropy / physiology*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage*
  • Leukocytes / drug effects
  • Leukocytes / enzymology*
  • Male
  • Middle Aged
  • Percutaneous Coronary Intervention / adverse effects*
  • Predictive Value of Tests
  • Preoperative Care* / methods
  • Treatment Outcome
  • rho-Associated Kinases / metabolism*

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • rho-Associated Kinases